You are here

T. Billiet

ECCO10 - T. Billiet

  • Disease burden outweighs the impact of drug concentrations and antibodies to infliximab in primary non-response to infliximab in Crohn’s disease patients
  • Closing remarks and take home message

Share

E-Alert

Subscribe to our E-Alert to stay informed of all new content as it's published on this platform.

IBD 13.03.2015

Visit the journal website!

Search form